URGN Competitors & Alternatives
Compare UroGen Pharma Ltd with similar stocks in the same industry
Biotechnology
URGN
Main Stock$26.33
Tradestie Score
61
Market Cap
$824.20M
Revenue Growth
2.2%
Analyst Upside
+130.6%
Top Competitors
216 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RAPP
Rapport Therapeutics, Inc. Common Stock
|
$26.44
|
$1.32B | - | 48 | Compare |
|
XERS
Xeris Biopharma Holdings, Inc. Common Stock
|
$16.47
|
$1.29B | - | 38 | Compare |
|
STOK
Stoke Therapeutics, Inc. Common Stock
|
$26.55
|
$1.29B | - | 54 | Compare |
|
ARDX
Ardelyx, Inc.
|
$3.13
|
$1.29B | - | 67 | Compare |
|
ZYME
Zymeworks Inc.
|
$27.16
|
$1.28B | 59.4 | 48 | Compare |
|
NUVB
Nuvation Bio Inc.
|
$4.08
|
$1.27B | - | 54 | Compare |
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$4.67
|
$1.18B | 45.2 | 65 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$49.56
|
$1.17B | - | 33 | Compare |
More URGN Analysis
Data updated: Nov 12, 2026 | Industry: Biotechnology (SIC 2834)
216 stocks in this industry